No CrossRef data available.
Article contents
Response of Tardive and L-Dopa-Induced Dyskinesias to Antidepressants
Published online by Cambridge University Press: 18 September 2015
Abstract:
Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
We report two patients with dyskinesia responding to antidepressants. The first is a 70-year-old man with depression, Parkinsonism and neuroleptic-induced tardive dyskinesia who presented with hysterical mutism. After recovery from the mutism, he was started on desipramine for depression. One week later the dyskinesia improved markedly. The second patient is a 61-year-old man with Parkinson's disease, dementia, depression and L-dopa-induced oro-lingual-facial dyskinesias. He was taking levodopa, trihexyphenydil and bromocriptine. The depression was treated first with desipramine and later with trazodone. The dyskinesia improved significantly on both drugs. The response of the dyskinesias to antidepressant medication may be due to the fact that antidepressants decrease beta-adrenoreceptor sensitivity and density which in turn may result in a diminished release of dopamine since beta-adrenoceptors mediate the noradrenaline-stimulated release of dopamine.
- Type
- Original Articles
- Information
- Copyright
- Copyright © Canadian Neurological Sciences Federation 1987
References
1.Seeman, P, Lee, T, Chau-Wong, K, Wong, M.Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 1976; 261: 717–719.CrossRefGoogle ScholarPubMed
2.Tarsy, D, Baldessarini, RJ.The pathophysiologic basis of tardive dyskinesia. Biol Psychiat 1977; 12: 431–450.Google ScholarPubMed
3.Muller, P, and Seeman, P.Brain neurotransmitter receptors after long-term haloperidol: dopamine, acetylcholine, serotonin, alpha-noradrenergic and naloxone receptors. Life Sci 1977; 21:1751–1758.CrossRefGoogle ScholarPubMed
4.Smith, JM, Baldessarini, RJ.Changes in prevalence, severity, and recovery in tardive dyskinesia with age. Arch Gen Psychiat 1980,37: 1368–1373.CrossRefGoogle ScholarPubMed
5.Ezrin-Waters, C, Seeman, MV, Seeman, P.Tardive dyskinesia in schizophrenic outpatients: prevalence and significant variables. J Clin Psychiat 1981; 42: 16–22.Google ScholarPubMed
6.Davis, KL, Berger, PA, Hollister, LE.Tardive dyskinesia and depressive illness. Psychopharmacol Commun 1976; 2: 125–130.Google ScholarPubMed
7.Rosenbaum, AH, Niven, RG, Hanson, NP, Swanson, DW.Tardive dyskinesia: relationship with a primary affective disorder. Dis Nerv Syst 1977; 38: 423–427.Google ScholarPubMed
8.Rush, M, Diamond, F, Alpert, M.Depression as a risk factor in tardive dyskinesia. Biol Psychiatry 1982; 17: 387–392.Google ScholarPubMed
9.Yassa, R, Nair, V, Schwartz, G.Tardive dyskinesia and the primary psychiatric diagnosis. Psychosomatics 1984; 25: 135–138.CrossRefGoogle ScholarPubMed
10.Shulman, KI, Silver, IL.Hysterical seizures as a manifestation of “depression” in old age. Can J Psychiatry 1985; 30: 278–280.CrossRefGoogle ScholarPubMed
11.Cutler, NR, Post, RM, Rey, AC, Bunney, WE.Depression-dependent dyskinesias in two cases of manic-depressive illness. N Engl J Med 1980; 304: 1088–1089.CrossRefGoogle Scholar
12.dePotter, RW, Linkowski, P, Mendlewicz, J.State-dependent tardive dyskinesia in manic-depressive illness. J Neurol Neurosurg Psych 1983; 46: 666–668.CrossRefGoogle Scholar
13.Rosenbaum, AM, Auger, RG, Maruta, T, Martin, DK, Duane, DD, Brenengen, EE.Tardive dyskinesia in depressed patients: Successful therapy with antidepressants and lithium. Psychosomatics 1980; 21: 715–719.CrossRefGoogle ScholarPubMed
14.Vetulani, J, Sulser, F.Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in limbic forebrain. Nature (London) 1975; 257: 495–496.CrossRefGoogle ScholarPubMed
15.Banerjee, SP, Kung, LS, Riggi, SJ, Chanda, SK.Development of beta-adrenergic receptor subsensitivity by antidepressants. Nature (London) 1977; 268: 455–456.CrossRefGoogle ScholarPubMed
16.Anden, NE, and Grabowska, M.Pharmacological evidence for a stimulation of dopamine neurons by noradrenaline neurons in the brain. Eur J Pharmacol 1976; 39: 275–282.CrossRefGoogle ScholarPubMed
17.Reisine, TD, Chesselet, MF, Lubetzki, C, Cheramy, A, Glowinski, J.Striatal beta-adrenergic receptors regulate dopamine release. Soc Neurosci Abstr 1981; 8: 526.Google Scholar
18.Langer, AZ.Presynaptic regulation of the release of catecholamines. Pharmacol Rev 1981; 32: 337–362.Google Scholar
19.Spyraki, C and Fibiger, HC.Behavioural evidence for super-sensitivity of postsynaptic dopamine receptors in the mesolimbic system after chronic administration of desipramine. Eur J Pharmacol 1981; 74: 195–206.CrossRefGoogle Scholar
20.Serrra, G, Argiolas, A, Klimek, V, Fadda, F, Gessa, GL.Chronic treatment with antidepressants prevents the inhibitory effect of small doses of apomorphine on dopamine synthesis and motor activity. Life Sci 1979; 25: 415–424.CrossRefGoogle Scholar
21.Chiodo, LA, Antelman, SM.Repeated tricyclics induce a progressive dopamine autoreceptor subsensitivity independent of daily drug treatment. Nature 1980; 287: 451–454.CrossRefGoogle ScholarPubMed
22.Serra, G, Argiolas, A, Fadda, F, Gessa, GL.Hyposensitivity of dopamine “autoreceptors” induced by chronic administration of tricyclic antidepressants. Pharmacol Res Commun 1980; 12: 619–624.CrossRefGoogle ScholarPubMed
You have
Access